43386-090 NDC - GAVILYTE G ()

Drug Information

Product NDC: 43386-090

Proprietary Name: GaviLyte G

Non Proprietary Name:

Active Ingredient(s):

Administration Route(s):

Dosage Form(s):

Pharmacy Class(es):

Increased Large Intestinal Motility [PE];
Increased Large Intestinal Motility [PE];
Increased Large Intestinal Motility [PE];
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
Osmotic Activity [MoA];
Osmotic Activity [MoA];
Osmotic Activity [MoA];
Osmotic Activity [MoA];
Osmotic Laxative [EPC];
Osmotic Laxative [EPC];
Osmotic Laxative [EPC];
Osmotic Laxative [EPC];
Potassium Compounds [CS];
Potassium Salt [EPC];
Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Labeler Information

Labeler Name:	Lupin Pharmaceuticals,Inc.
Product Type:
FDA Application Number:
Marketing Category:
Start Marketing Date:	6/1/2009

Package Information

No.	Package Code	Package Description	Billing Unit
1	43386-090-19	274.31 g in 1 BOTTLE (43386-090-19)	ML
2	43386-090-91	274.31 g in 1 BOTTLE (43386-090-91)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	43386-090	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	GaviLyte G	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX	TM	A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE	6/1/2009	This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAME	Lupin Pharmaceuticals,Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC	43386-090	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAME	GAVILYTE G	The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
PROPRIETARY NAME SUFFIX	TM	A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
START MARKETING DATE	6/1/2009	This is the date that the labeler indicates was the start of its marketing of the drug product.
LABELER NAME	Lupin Pharmaceuticals,Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Export to text format icon Download this NDC record in Text format: Export

Export to text format icon Download this NDC record in Excel (CSV) format: Export

Export to text format icon Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023

« Previous Code

Next Code »